“…These included HoxA7/9 (B cell development) [16], Pou2f2 (transcriptional activator of immunoglobulin expression) [30], Ciapin1 (cytokine-induced apoptosis inhibitor) [31], E2f1/2 (transcriptional activator, cellular proliferation) [32], CD33 (monocyte cell adhesion molecule) [33], Stra13 (positive regulator of T cell activation) [34], Ms4a4b (CD20 homolog, T cell differentiation) [35], transcription factor E3/ EB (CD40 dependent CD4 T cell-dependent antibody production) [36], CXCR4 (lymphocyte chemotaxis) [37], Bap31 (MHC class 1 export) [38], CD22 (regulation of B cell signalling) [39], Ccl11 (Eotaxin 1, eosinophil recruitment) [40], CCR9 (mucosal lymphocyte recruitment) [41], C-src tyrosine kinase (T cell activation) [42], and FMS-like tyrosine kinase 4 (lymphatic development) [43]. This finding suggests that a key component of the early inflammatory response in IA is the activation of genes involved in lymphoproliferative responses.…”